Upper airway obstruction (UAO) can result in cardiac complications, including arrhythmias and sudden cardiac death. Nasal septum deviation (NSD) is a common cause of UAO. The aim of this study was to assess the risk of cardiac arrhythmias in patients with NSD. To assess this risk, we measured noninvasive indicators of atrial arrhythmia (P-wave dispersion [Pd]) and ventricular arrhythmia (corrected QT dispersion [QTcd]) and compared these values between NSD patients and healthy subjects.
Study Design
Prospective study.
Settings
Tertiary referral center.
Subjects and Methods
This study included 53 consecutive patients who had underwent septoplasty due to marked NSD. Electrocardiographic records were used to determine Pd and QTcd values preoperatively and 6 months postoperatively. Fifty-three consecutive age- and sex-matched subjects without any UAO were also examined as a control group.
Results
Preoperative Pd and QTcd values were significantly higher in NSD patients than in the control group (Pd: 57.40 ± 14.21 vs 34.11 ± 7.12 milliseconds, P < .001; QTcd: 81.77 ± 16.39 vs 50.25 ± 11.51 milliseconds, P < .001, respectively). In addition, Pd and QTcd values were significantly greater in preoperative NSD patients when compared with the same patients postoperatively (Pd: 57.40 ± 14.21 vs 36.32 ± 8.9 milliseconds, P = .013; QTcd: 81.77 ± 16.39 vs 55.76 ± 11.4 milliseconds, P = .012, respectively).
Conclusion
In conclusion, NSD patients are at risk for both atrial and ventricular cardiac arrhythmias; however, septoplasty in these patients can relieve UAO and reduce the risk of arrhythmias.
GozalDKheirandish-GozalL. Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. Am J Respir Crit Care Med. 2008;177:369-375.
4.
IshiiLGodoyAIshmanSLGourinCGIshiiMl. The nasal obstruction symptom evaluation survey as a screening tool for obstructive sleep apnea. Arch Otolaryngol Head Neck Surg. 2011;137:119-123.
KocabaşASalmanNEkiciFCetinIAkcanFA. Evaluation of cardiac functions and atrial electromechanical delay in children with adenotonsillar hypertrophy. Pediatr Cardiol. 2014;35:785-792.
7.
JaziMHAmraBYazdchiMRJahangiriMTabeshFGholamrezaeiA. P wave duration and dispersion in Holter electrocardiography of patients with obstructive sleep apnea. Sleep Breath. 2014;18:549-554.
8.
DilaverisPEGialafosJE. P-wave dispersion: a novel predictor of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol. 2001;6:159-165.
9.
DilaverisPBatchvarovVGialafosJMaikM. Comparison of different methods for manual P wave duration measurement in 12-lead electrocardiograms. Pacing Clin Electrophysiol. 1999;22:1532-1538.
10.
PyeMQuinnACCobbeSM. QT interval dispersion: a non-invasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias?Br Heart J. 1994;71:511-514.
11.
MalikMBatchvarovVN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol. 2000;36:1749-1766.
12.
AkbalAKurtaranAGürcanA. P-wave and QT dispersion in spinal cord injury. Intern Med. 2014;53:1607-1611.
13.
IzciFHocagilHIzciSIzciVKocMIAcarRD. P-wave and QT dispersion in patients with conversion disorder. Ther Clin Risk Manag. 2015;11:475-480.
14.
SeyfeliEDuruMKuvandikGKayaHYalcinF. Effect of obesity on P-wave dispersion and QT dispersion in women. Int J Obes (Lond). 2006;30:957-961.
15.
GuntekinUGunesYTuncerMGumrukcuogluHAKayaY. The effect of altitude on P-wave and QT duration and dispersion. Pacing Clin Electrophysiol. 2008;31:889-892.
16.
JohnsMW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540-545.
17.
JohnsMW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep. 1992;15:376-381.
18.
BazettH. An analysis of the time-relations of electrocardiograms. Heart. 1920;7:353–370.
19.
LiistroGRombauxPhBelgeCDuryMAubertGRodensteinDO. High Mallampati score and nasal obstruction are associated risk factors for obstructive sleep apnea. Eur Respir J. 2003;21:248-252.
20.
Michels DdeSRodrigues AdaMNakanishiMSampaioALVenosaAR. Nasal involvement in obstructive sleep apnea syndrome. Int J Otolaryngol. 2014;2014:717419
21.
VerseTPirsigW. Impact of impaired nasal breathing on sleep-disordered breathing. Sleep Breath. 2003;7:63-76.
22.
FerrisBGJrMeadJOpieLH. Partitioning of respiratory flow resistance in man. J Appl Physiol. 1964;19:653-658.
23.
OlsenKDKernEBWestbrookPR. Sleep and breathing disturbance secondary to nasal obstruction. Otolaryngol Head Neck Surg. 1981;89:804-810.
O’ConnorPJMerrillGF. Ventricular arrhythmias caused by repeat exposure to hypoxia are dependent on duration of reoxygenation. FASEB J. 1995;9:387-391.
26.
WiklundUOlofssonBOFranklinKBlomHBjerlePNiklassonU. Autonomic cardiovascular regulation in patients with obstructive sleep apnoea: a study based on spectral analysis of heart rate variability. Clin Physiol. 2000;20:234-241.
27.
McNicholasWTBonsigoreMR. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J. 2007;29:156-178.
28.
RinglerJGarpestadEBasnerRWeissJW. Systemic blood pressure elevation after airway occlusion during NREM sleep. Am J Respir Crit Care Med. 1994;150:1062-1066.
29.
WeissJWRemsburgSGarpestadERinglerJSparrowDParkerJA. Hemodynamic consequences of obstructive sleep apnea. Sleep. 1996;19:388-397.
30.
SanoKWatanabeEHayanoJ. Central sleep apnoea and inflammation are independently associated with arrhythmia in patients with heart failure. Eur J Heart Fail. 2013;15:1003-1010.
31.
GramleyFLorenzenJJedamzikB. Atrial fibrillation is associated with cardiac hypoxia. Cardiovasc Pathol. 2010;19:102-111.
32.
YoungTFinnLKimH. Nasal obstruction as a risk factor for sleep-disordered breathing: the University of Wisconsin Sleep and Respiratory Research Group. J Allergy Clin Immunol. 1997;99:S757-S762.
33.
LiistroGRombauxPhBelgeCDuryMAubertGRodensteinDO. High Mallampati score and nasal obstruction are associated risk factors for obstructive sleep apnea. Eur Respir J. 2003;21:248-252.
34.
WilhoitSCSurattPM. Effect of nasal obstruction on upper airway muscle activation in normal subjects. Chest. 1987;92:1053-1055.
35.
MilicićDMladinaRDjanićDPrgometDLeović. Influence of nasal fontanel receptors on the regulation of tracheobronchal vagal tone. Croat Med J. 1998;39:426-429.
36.
TanakaYHondaY. Nasal obstruction as a cause of reduced PCO2 and disordered breathing during sleep. J Appl Physiol (1985). 1989;67:970-972.
37.
NakataSNodaAYasumaF. Effects of nasal surgery on sleep quality in obstructive sleep apnea syndrome with nasal obstruction. Am J Rhinol. 2008;22:59-63.
38.
FidanVAksakalE. Impact of septoplasty on pulmonary artery pressure in patients with markedly deviated septum. J Craniofac Surg. 2011;22:1591-1593.
39.
PotsicWPPasquarielloPSBaranakCCMarshRRMillerLM. Relief of upper airway obstruction by adenotonsillectomy. Otolaryngol Head Neck Surg. 1986;94:476-480.
40.
DerinSAkınFŞahanMAltunİŞahinCEliçoraSŞ. Impact of markedly nasal septal deviation on 24-hour rhythm Holter findings. Kulak Burun Bogaz Ihtis Derg. 2015;25:284-288.
41.
OkinPMDevereuxRBHowardBVFabsitzRRLeeETWeltyTK. Assesment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: the Strong Heart Study. Circulation. 2000;101:61-66.
42.
NussinovitchU. Meta-analysis of p-wave dispersion values in healthy individuals: the influence of clinical characteristics. Ann Noninvasive Electrocardiol. 2012;17:28-35.
43.
DilaverisPEGialafosEJSiderisSK. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J. 1998;135:733-738.
